Moderna and OpenAI Collaborate To Advance mRNA Medicine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
April 24, 2024 12:31 PM EDTMorgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $89.00 price target on Moderna (NASDAQ: MRNA)
The analyst comments "MRNA announced an update regarding the company's ongoing collaboration with OpenAI (privately held) on generative AI tools, noting that the ChatGPT Enterprise is embedded across MRNA's business functions and has achieved more than 80% internal adoption throughout... More



